✦ LIBER ✦

Health-Related Quality of Life in Younger Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine Plus Cyclophosphamide or Fludarabine Alone for First-Line Therapy: A Study by the German CLL Study Group

✍ Scribed by Eichhorst, B. F.; Busch, R.; Obwandner, T.; Kuhn-Hallek, I.; Herschbach, P.; Hallek, M.

Book ID: 118019048
Publisher: American Society of Clinical Oncology
Year: 2007
Tongue: English
Weight: 191 KB
Volume: 25
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2006.05.6929

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Cladribine Plus Cyclophosp

Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)

✍ Robak, T.; Jamroziak, K.; Gora-Tybor, J.; Stella-Holowiecka, B.; Konopka, L.; Ce 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 164 KB

5.40 Rituximab Maintenance in Patients w

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

✍ Francesc Bosch; Pau Abrisqueta; Neus Villamor; María José Terol; Eva González-Ba 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 250 KB